Schreiner MediPharm has further developed Flexi-Cap, its innovative first-opening indication security concept, for oncological applications: An additional cap protects the bottom of bottles or vials against glass breakage and surface contamination.
Schreiner MediPharm has further developed Flexi-Cap, its innovative first-opening indication security concept, for oncological applications. Flexi cap features a cap which covers the closure and upper part of the container. In addition to this it fetures a second cap is added to protect the bottom and lower part. Both caps are affixed to the container using a label, which can optionally be provided with an integrated foam layer to provide further protection against lateral impact. Consequently, the container’s surface is completely protected. Another important aspect: The two caps and label are applied without heat, so that the medicine’s properties are not impaired. In addition, the upper cap offers space for imprinting warning notices, codes for track & trace systems or integrating NFC inlays for interactive applications. Cytostatics are highly potent substances to combat cancer cells, but they are extremely toxic for healthy cells. Therefore, it is imperative to protect packaging against surface contamination and glass breakage. In spite of sophisticated filling and packaging processes in the production of pharmaceuticals, contamination of primary packaging cannot be completely avoided. Moreover, glass breakage of primary containers with cytostatics can have serious consequences. The different functions of the newly developed special solution Flexi-Cap Protect ensure the protection of users against the severe consequences of possible contamination and simultaneously guarantee the integrity of primary packaging.